Literature DB >> 23723351

piggyBac transposase tools for genome engineering.

Xianghong Li1, Erin R Burnight, Ashley L Cooney, Nirav Malani, Troy Brady, Jeffry D Sander, Janice Staber, Sarah J Wheelan, J Keith Joung, Paul B McCray, Frederic D Bushman, Patrick L Sinn, Nancy L Craig.   

Abstract

The transposon piggyBac is being used increasingly for genetic studies. Here, we describe modified versions of piggyBac transposase that have potentially wide-ranging applications, such as reversible transgenesis and modified targeting of insertions. piggyBac is distinguished by its ability to excise precisely, restoring the donor site to its pretransposon state. This characteristic makes piggyBac useful for reversible transgenesis, a potentially valuable feature when generating induced pluripotent stem cells without permanent alterations to genomic sequence. To avoid further genome modification following piggyBac excision by reintegration, we generated an excision competent/integration defective (Exc(+)Int(-)) transposase. Our findings also suggest the position of a target DNA-transposase interaction. Another goal of genome engineering is to develop reagents that can guide transgenes to preferred genomic regions. Others have shown that piggyBac transposase can be active when fused to a heterologous DNA-binding domain. An Exc(+)Int(-) transposase, the intrinsic targeting of which is defective, might also be a useful intermediate in generating a transposase whose integration activity could be rescued and redirected by fusion to a site-specific DNA-binding domain. We show that fusion to two designed zinc finger proteins rescued the Int(-) phenotype. Successful guided transgene integration into genomic DNA would have broad applications to gene therapy and molecular genetics. Thus, an Exc(+)Int(-) transposase is a potentially useful reagent for genome engineering and provides insight into the mechanism of transposase-target DNA interaction.

Entities:  

Keywords:  GULOP; ROSA26; induced pluripotent stem cell production; protein-DNA interaction

Mesh:

Substances:

Year:  2013        PMID: 23723351      PMCID: PMC3690869          DOI: 10.1073/pnas.1305987110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  piggyBac is a flexible and highly active transposon as compared to sleeping beauty, Tol2, and Mos1 in mammalian cells.

Authors:  Sareina Chiung-Yuan Wu; Yaa-Jyuhn James Meir; Craig J Coates; Alfred M Handler; Pawel Pelczar; Stefan Moisyadi; Joseph M Kaminski
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-27       Impact factor: 11.205

2.  PiggyBac transposon-based inducible gene expression in vivo after somatic cell gene transfer.

Authors:  Sai K Saridey; Li Liu; Joseph E Doherty; Aparna Kaja; Daniel L Galvan; Bradley S Fletcher; Matthew H Wilson
Journal:  Mol Ther       Date:  2009-10-06       Impact factor: 11.454

3.  Manipulating piggyBac transposon chromosomal integration site selection in human cells.

Authors:  Claudia Kettlun; Daniel L Galvan; Alfred L George; Aparna Kaja; Matthew H Wilson
Journal:  Mol Ther       Date:  2011-07-05       Impact factor: 11.454

4.  Excision of the piggyBac transposable element in vitro is a precise event that is enhanced by the expression of its encoded transposase.

Authors:  T A Elick; C A Bauser; M J Fraser
Journal:  Genetica       Date:  1996-07       Impact factor: 1.082

5.  Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system.

Authors:  S R Yant; L Meuse; W Chiu; Z Ivics; Z Izsvak; M A Kay
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

6.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

Review 7.  Translating Sleeping Beauty transposition into cellular therapies: victories and challenges.

Authors:  Zsuzsanna Izsvák; Perry B Hackett; Laurence J N Cooper; Zoltán Ivics
Journal:  Bioessays       Date:  2010-09       Impact factor: 4.345

8.  piggyBac can bypass DNA synthesis during cut and paste transposition.

Authors:  Rupak Mitra; Jennifer Fain-Thornton; Nancy L Craig
Journal:  EMBO J       Date:  2008-03-20       Impact factor: 11.598

9.  Mutational analysis of highly conserved aspartate residues essential to the catalytic core of the piggyBac transposase.

Authors:  James H Keith; Cheryl A Schaeper; Tresa S Fraser; Malcolm J Fraser
Journal:  BMC Mol Biol       Date:  2008-08-11       Impact factor: 2.946

10.  piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells.

Authors:  Knut Woltjen; Iacovos P Michael; Paria Mohseni; Ridham Desai; Maria Mileikovsky; Riikka Hämäläinen; Rebecca Cowling; Wei Wang; Pentao Liu; Marina Gertsenstein; Keisuke Kaji; Hoon-Ki Sung; Andras Nagy
Journal:  Nature       Date:  2009-03-01       Impact factor: 49.962

View more
  86 in total

1.  PiggyBac as a novel vector in cancer gene therapy: current perspective.

Authors:  H Mirzaei; A Sahebkar; M R Jaafari; J Hadjati; S H Javanmard; H R Mirzaei; R Salehi
Journal:  Cancer Gene Ther       Date:  2016-01-08       Impact factor: 5.987

2.  A non-autonomous insect piggyBac transposable element is mobile in tobacco.

Authors:  Eric T Johnson; Patrick F Dowd
Journal:  Mol Genet Genomics       Date:  2014-05-24       Impact factor: 3.291

3.  Derivation and characterization of bovine induced pluripotent stem cells by transposon-mediated reprogramming.

Authors:  Thirumala R Talluri; Dharmendra Kumar; Silke Glage; Wiebke Garrels; Zoltan Ivics; Katharina Debowski; Rüdiger Behr; Heiner Niemann; Wilfried A Kues
Journal:  Cell Reprogram       Date:  2015-04       Impact factor: 1.987

4.  Efficient, footprint-free human iPSC genome editing by consolidation of Cas9/CRISPR and piggyBac technologies.

Authors:  Gang Wang; Luhan Yang; Dennis Grishin; Xavier Rios; Lillian Y Ye; Yong Hu; Kai Li; Donghui Zhang; George M Church; William T Pu
Journal:  Nat Protoc       Date:  2016-12-08       Impact factor: 13.491

5.  A stable but reversible integrated surrogate reporter for assaying CRISPR/Cas9-stimulated homology-directed repair.

Authors:  Yahong Wen; Grace Liao; Thomas Pritchard; Ting-Ting Zhao; Jon P Connelly; Shondra M Pruett-Miller; Valerie Blanc; Nicholas O Davidson; Blair B Madison
Journal:  J Biol Chem       Date:  2017-02-22       Impact factor: 5.157

Review 6.  Exogenous enzymes upgrade transgenesis and genetic engineering of farm animals.

Authors:  Pablo Bosch; Diego O Forcato; Fabrisio E Alustiza; Ana P Alessio; Alejandro E Fili; María F Olmos Nicotra; Ana C Liaudat; Nancy Rodríguez; Thirumala R Talluri; Wilfried A Kues
Journal:  Cell Mol Life Sci       Date:  2015-02-01       Impact factor: 9.261

7.  Excision efficiency is not strongly coupled to transgenic rate: cell type-dependent transposition efficiency of sleeping beauty and piggyBac DNA transposons.

Authors:  Orsolya Kolacsek; Zsuzsa Erdei; Agota Apáti; Sára Sándor; Zsuzsanna Izsvák; Zoltán Ivics; Balázs Sarkadi; Tamás I Orbán
Journal:  Hum Gene Ther Methods       Date:  2014-08       Impact factor: 2.396

Review 8.  Modulating signaling networks by CRISPR/Cas9-mediated transposable element insertion.

Authors:  Luis María Vaschetto
Journal:  Curr Genet       Date:  2017-10-14       Impact factor: 3.886

9.  Immortalized Mouse Achilles Tenocytes Demonstrate Long-Term Proliferative Capacity While Retaining Tenogenic Properties.

Authors:  Sahitya K Denduluri; Bryan Scott; Joseph D Lamplot; Liangjun Yin; Zhengjian Yan; Zhongliang Wang; Jixing Ye; Jing Wang; Qiang Wei; Maryam K Mohammed; Rex C Haydon; Richard W Kang; Tong-Chuan He; Aravind Athiviraham; Sherwin H Ho; Lewis L Shi
Journal:  Tissue Eng Part C Methods       Date:  2016-03       Impact factor: 3.056

Review 10.  Retinal repair with induced pluripotent stem cells.

Authors:  Shomoukh Al-Shamekh; Jeffrey L Goldberg
Journal:  Transl Res       Date:  2013-11-08       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.